Tag: FDA approval
30-Month Stay: How Patent Litigation Delays Generic Drug Approval
The 30-month stay under the Hatch-Waxman Act delays generic drug approval by freezing FDA approval during patent litigation. Learn how this legal tool is used - and abused - to block cheaper medications, costing billions annually.
